The main goals of this study are to correlate the different histologic subtypes of canine lymphoma with gene expression and response to treatment and survival time.
All dogs with newly diagnosed multicentric lymphoma that have enlarged peripheral lymph nodes are eligible for entry into this study.
Patients that have received prior chemotherapy are not eligible for participation in this study.
The owner is financially responsible for all tests that determine if the patient qualifies for the study. These tests may include initial specialty examination, blood and urine tests.
The study will cover the costs of blood collection and histopathologic evaluation, including immunophenotype of your dog’s lymph node tissue (if applicable).
Kelly Reed, Oncology Liaison
Phone: (508) 887-4682